| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1020764738 |
| P356 | DOI | 10.1038/SJ.ONC.1209104 |
| P698 | PubMed publication ID | 16186800 |
| P2093 | author name string | Kim I | |
| Khokha R | |||
| Cruz-Muñoz W | |||
| P2860 | cites work | A matrix metalloproteinase expressed on the surface of invasive tumour cells | Q24312733 |
| A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 | Q28185858 | ||
| Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations | Q29544430 | ||
| Role of angiogenesis in tumor growth and metastasis | Q29614309 | ||
| Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma | Q29615947 | ||
| How matrix metalloproteinases regulate cell behavior | Q29620360 | ||
| TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix | Q30886270 | ||
| Matrix metalloproteinases and metastasis | Q33651977 | ||
| Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer. | Q33959697 | ||
| Diminished corneal angiogenesis in gelatinase A-deficient mice | Q34102769 | ||
| Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. | Q34733220 | ||
| Matrix metalloproteinases in tumor-host cell communication | Q35030681 | ||
| Role of TIMPs (tissue inhibitors of metalloproteinases) in pericellular proteolysis: the specificity is in the detail | Q35572214 | ||
| Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). | Q36041136 | ||
| Accelerated apoptosis in the Timp-3-deficient mammary gland | Q36041423 | ||
| Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes | Q37407293 | ||
| Retroviral vector-producer cell-mediated in vivo gene transfer of TIMP-3 restricts angiogenesis and neuroblastoma growth in mice | Q40663909 | ||
| Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3. | Q41171604 | ||
| Molecular cloning of mouse tissue inhibitor of metalloproteinases-3 and its promoter. Specific lack of expression in neoplastic JB6 cells may reflect altered gene methylation | Q41310309 | ||
| A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth | Q41481835 | ||
| Gene trapping identifies inhibitors of oncogenic transformation. The tissue inhibitor of metalloproteinases-3 (TIMP3) and collagen type I alpha2 (COL1A2) are epidermal growth factor-regulated growth repressors | Q42829691 | ||
| Inhibition of the putative tumor suppressor gene TIMP-3 by tumor-derived p53 mutants and wild type p53. | Q43831424 | ||
| Membrane-type matrix metalloproteinases in human dermal microvascular endothelial cells: expression and morphogenetic correlation | Q46138364 | ||
| Randomized phase III study of matrix metalloproteinase inhibitor BMS-275291 in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18. | Q46443861 | ||
| Permeability-related changes revealed at endothelial cell borders in inflamed venules by lectin binding. | Q50533589 | ||
| Enforced expression of tissue inhibitor of matrix metalloproteinase-3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor model. | Q51700781 | ||
| High levels of TIMP-2 correlate with adverse prognosis in breast cancer. | Q52141709 | ||
| Frequent methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene in pancreatic endocrine tumors. | Q54785034 | ||
| Expression and Prognostic Significance of Metalloproteinases and Their Tissue Inhibitors in Patients With Small-Cell Lung Cancer | Q57272687 | ||
| Combination of Tumor Necrosis Factor-α Ablation and Matrix Metalloproteinase Inhibition Prevents Heart Failure After Pressure Overload in Tissue Inhibitor of Metalloproteinase-3 Knock-Out Mice | Q58211733 | ||
| Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in esophageal carcinoma | Q73141823 | ||
| Complex role of matrix metalloproteinases in angiogenesis | Q77474882 | ||
| Increased expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 is correlated with poor prognostic variables in patients with thymic epithelial tumors | Q79219734 | ||
| Promoter hypermethylation profile of kidney cancer | Q80242653 | ||
| P433 | issue | 4 | |
| P921 | main subject | angiogenesis | Q539568 |
| P304 | page(s) | 650-655 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | TIMP-3 deficiency in the host, but not in the tumor, enhances tumor growth and angiogenesis | |
| P478 | volume | 25 |
| Q91999106 | Breast Cancer Tumor Stroma: Cellular Components, Phenotypic Heterogeneity, Intercellular Communication, Prognostic Implications and Therapeutic Opportunities |
| Q34876809 | Cell surface-bound TIMP3 induces apoptosis in mesenchymal Cal78 cells through ligand-independent activation of death receptor signaling and blockade of survival pathways |
| Q83350739 | Enhanced metastatic dissemination to multiple organs by melanoma and lymphoma cells in timp-3-/- mice |
| Q79370590 | Expression profiles associated with aggressive behavior in Merkel cell carcinoma |
| Q42699734 | Extracellular matrix proteins and tumor angiogenesis |
| Q42276486 | Giving blood: a new role for CD40 in tumorigenesis |
| Q33808182 | Increased neovascularization in mice lacking tissue inhibitor of metalloproteinases-3. |
| Q37122785 | Inhibition of microRNA-126 promotes the expression of Spred1 to inhibit angiogenesis in hepatocellular carcinoma after transcatheter arterial chemoembolization: in vivo study |
| Q39792473 | Inhibition of tumor growth and induction of apoptosis in prostate cancer cell lines by overexpression of tissue inhibitor of matrix metalloproteinase-3. |
| Q38963422 | Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state |
| Q36903488 | Pathophysiological mechanisms of angiogenesis. |
| Q37777976 | Proteases in cutaneous malignant melanoma: relevance as biomarker and therapeutic target. |
| Q59339812 | Signatures of selection and environmental adaptation across the goat genome post-domestication |
| Q91404780 | Sorsby Fundus Dystrophy Mutation in Tissue Inhibitor of Metalloproteinase 3 (TIMP3) promotes Choroidal Neovascularization via a Fibroblast Growth Factor-dependent Mechanism |
| Q38663477 | Sphingosine-1-phosphate suppresses chondrosarcoma metastasis by upregulation of tissue inhibitor of metalloproteinase 3 through suppressing miR-101 expression. |
| Q41610199 | Stroma-derived but not tumor ADAMTS1 is a main driver of tumor growth and metastasis |
| Q35568697 | Stromal cell-derived CSF-1 blockade prolongs xenograft survival of CSF-1-negative neuroblastoma |
| Q92277219 | TIMP-3 as a therapeutic target for cancer |
| Q38785433 | TIMPs: versatile extracellular regulators in cancer |
| Q37324256 | The ADAMs: signalling scissors in the tumour microenvironment |
| Q33786342 | The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity |
| Q35217321 | Timp3 deficient mice show resistance to developing breast cancer |
| Q35152040 | Tissue inhibitor of metalloproteinase-3 (TIMP3) promotes endothelial apoptosis via a caspase-independent mechanism |
Search more.